Ameriprise
LMAT icon

Ameriprise’s LeMaitre Vascular LMAT Stock Holding History

Ameriprise’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.2M Sell
148,416
-15,863
-10% -$1.51M ﹤0.01% 1564
2025
Q4 		$13.3M Sell
164,279
-2,555
-2% -$220K ﹤0.01% 1698
2025
Q3 		$14.6M Sell
166,834
-64,448
-28% -$5.76M ﹤0.01% 1625
2025
Q2 		$19.2M Buy
231,282
+28,556
+14% +$2.39M ﹤0.01% 1392
2025
Q1 		$17M Buy
202,726
+22,039
+12% +$2.05M ﹤0.01% 1413
2024
Q4 		$16.6M Sell
180,687
-60,418
-25% -$5.81M ﹤0.01% 1459
2024
Q3 		$22.4M Sell
241,105
-16,265
-6% -$1.41M 0.01% 1269
2024
Q2 		$21.2M Sell
257,370
-18,018
-7% -$1.32M 0.01% 1246
2024
Q1 		$18.3M Sell
275,388
-10,034
-4% -$619K 0.01% 1352
2023
Q4 		$16.2M Buy
285,422
+22,149
+8% +$1.16M ﹤0.01% 1397
2023
Q3 		$14.3M Sell
263,273
-13,632
-5% -$808K ﹤0.01% 1443
2023
Q2 		$18.6M Sell
276,905
-35,214
-11% -$2.15M 0.01% 1316
2023
Q1 		$16.1M Buy
312,119
+36,866
+13% +$1.79M 0.01% 1423
2022
Q4 		$12.7M Sell
275,253
-4,325
-2% -$203K ﹤0.01% 1546
2022
Q3 		$14.2M Sell
279,578
-968
-0.3% -$48.4K 0.01% 1410
2022
Q2 		$12.8M Buy
280,546
+7,540
+3% +$337K ﹤0.01% 1538
2022
Q1 		$12.7M Buy
273,006
+7,624
+3% +$341K ﹤0.01% 1707
2021
Q4 		$13.3M Sell
265,382
-824
-0.3% -$42.6K ﹤0.01% 1740
2021
Q3 		$14.1M Sell
266,206
-70,618
-21% -$3.98M ﹤0.01% 1559
2021
Q2 		$20.6M Buy
336,824
+12,945
+4% +$688K 0.01% 1334
2021
Q1 		$15.8M Buy
323,879
+65,087
+25% +$3.05M 0.01% 1510
2020
Q4 		$10.5M Sell
258,792
-8,835
-3% -$316K ﹤0.01% 1722
2020
Q3 		$8.71M Sell
267,627
-17,378
-6% -$522K ﹤0.01% 1649
2020
Q2 		$7.52M Sell
285,005
-68,859
-19% -$1.8M ﹤0.01% 1749
2020
Q1 		$8.82M Buy
353,864
+34,277
+11% +$1.06M ﹤0.01% 1480
2019
Q4 		$11.5M Sell
319,587
-3,165
-1% -$109K ﹤0.01% 1631
2019
Q3 		$11M Buy
322,752
+28,654
+10% +$916K ﹤0.01% 1621
2019
Q2 		$8.23M Sell
294,098
-8,540
-3% -$237K ﹤0.01% 1882
2019
Q1 		$9.38M Sell
302,638
-25,365
-8% -$677K ﹤0.01% 1747
2018
Q4 		$7.75M Sell
328,003
-45,080
-12% -$1.23M ﹤0.01% 1808
2018
Q3 		$14.5M Buy
373,083
+75,130
+25% +$2.71M 0.01% 1575
2018
Q2 		$9.97M Sell
297,953
-90,702
-23% -$3.23M ﹤0.01% 1741
2018
Q1 		$14.1M Buy
388,655
+121,893
+46% +$4.22M 0.01% 1375
2017
Q4 		$8.49M Buy
266,762
+67,489
+34% +$2.31M ﹤0.01% 1733
2017
Q3 		$7.46M Buy
199,273
+44,801
+29% +$1.52M ﹤0.01% 1790
2017
Q2 		$4.82M Sell
154,472
-47,036
-23% -$1.36M ﹤0.01% 2099
2017
Q1 		$4.96M Buy
201,508
+69,186
+52% +$1.62M ﹤0.01% 2058
2016
Q4 		$3.35M Buy
132,322
+43,090
+48% +$956K ﹤0.01% 2352
2016
Q3 		$1.77M Buy
89,232
+13,323
+18% +$233K ﹤0.01% 2632
2016
Q2 		$1.08M Buy
+75,909
New +$1.16M ﹤0.01% 2848

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Ameriprise's LMAT Position: Q1 2026 in Review

Ameriprise reduced its LeMaitre Vascular (LMAT) stake by 9.7% in Q1 2026, selling an estimated $1.51M and leaving 148,416 shares worth $16.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1564.

Ameriprise first reported a position in LMAT in Q2 2016 and has held it in 40 quarters since. The position peaked at $22.4M in Q3 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Ameriprise held 148,416 shares of LeMaitre Vascular worth $16.2M as of Q1 2026.
  • Ameriprise sold 15,863 LeMaitre Vascular shares in Q1 2026, an estimated $1.51M.
  • LeMaitre Vascular made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #1564 holding.
  • Ameriprise first reported a position in LeMaitre Vascular in Q2 2016 and has held it in 40 quarters since.
  • Ameriprise's LeMaitre Vascular position peaked at $22.4M in Q3 2024.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.